Stage FocusSeed, Series A, Series B+
GeographyUS
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedtech
Technical BenchStrong
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio
Perceptive Xontogeny Venture Fund is the venture capital strategy of Perceptive Advisors, a New York-based life sciences investment firm founded in 1999 that manages roughly $11 billion across its strategies. The venture strategy launched with its first closed-end fund in 2018 and closed Fund II in 2021, and now manages over $700 million dedicated to financing early-stage life sciences companies, ...
Similar Funds
3B
3E Bioventures Capital
China
Pure DeepTechBiotechMedtechSeedSeries A
AL
Advent Life Sciences
London, United Kingdom
Pure DeepTechBiotechMedtechSeedSeries A
AV
Alix Ventures
San Francisco, United States
Pure DeepTechBiotechSynthetic BiologyMedtechPre-SeedSeed
Bold Capital Partners
Santa Monica, United States
Pure DeepTechBiotechAIMedtechSeedSeries A
DA
Domain Associates
United States
Pure DeepTechBiotechMedtechSeedSeries A
DC
Dynamk Capital
New York, United States
Pure DeepTechBiotechMedtechHardwareSeedSeries A